Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis
Нейромедиаторы: ключевые модуляторы, регулирующие ось «кишечник — мозг»
2016-08-11
SCID: 54.1/3qerh3y7
Discuss with AI
catecholaminesgastrointestinal physiologygut–brain axisinflammatory bowel diseaseneurotransmitters
Figures from the paper
Abstract (AI)
Neurotransmitters, including catecholamines and serotonin, play a crucial role in maintaining homeostasis in the human body. Studies on these neurotransmitters mainly revolved around their role in the "fight or flight" response, transmitting signals across a chemical synapse and modulating blood flow throughout the body. However, recent research has demonstrated that neurotransmitters can play a significant role in the gastrointestinal (GI) physiology. Norepinephrine (NE), epinephrine (E), dopamine (DA), and serotonin have recently been a topic of interest because of their roles in the gut physiology and their potential roles in GI and central nervous system pathophysiology. These neurotransmitters are able to regulate and control not only blood flow, but also affect gut motility, nutrient absorption, GI innate immune system, and the microbiome. Furthermore, in pathological states, such as inflammatory bowel disease (IBD) and Parkinson's disease, the levels of these neurotransmitters are dysregulated, therefore causing a variety of GI symptoms. Research in this field has shown that exogenous manipulation of catecholamine serum concentrations can help in decreasing symptomology and/or disease progression. In this review article, we discuss the current state-of-the-art research and literature regarding the role of neurotransmitters in regulation of normal GI physiology, their impact on several disease processes, and novel work focused on the use of exogenous hormones and/or psychotropic medications to improve disease symptomology. J. Cell. Physiol. 232: 2359-2372, 2017. © 2016 Wiley Periodicals, Inc.
Key Findings
1
Catecholamines and serotonin regulate gastrointestinal physiology beyond their classical roles in synaptic signaling, stress responses, and blood-flow modulation.
2
Exogenous manipulation of catecholamine concentrations may reduce gastrointestinal symptom severity and/or slow disease progression.
3
Neurotransmitter levels become dysregulated in conditions including inflammatory bowel disease and Parkinson’s disease, contributing to gastrointestinal symptoms.
4
The review evaluates neurotransmitter regulation of normal gut physiology, disease mechanisms, and potential therapeutic use of exogenous hormones or psychotropic medications.
5
These neurotransmitters influence gut motility, nutrient absorption, gastrointestinal innate immunity, and the composition or function of the gut microbiome.
Research Object
Neurotransmitters in the gastrointestinal system and gut–brain axis
Research Subject
Their regulation of normal gastrointestinal physiology, effects on gastrointestinal and central nervous system pathophysiology, and therapeutic modulation of disease symptoms
Publication Details
Publication Date
2016-08-11
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest